This website is intended for UK healthcare professionals only Log in | Register

Editorial articles

March 2005 Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 5–AIC 7

Interventional cardiology training in the UK: time for a change?

Nick Curzen

Abstract

The current specialist registrar (SpR) training system in the UK is necessarily built on the foundation of general training in cardiology. The acquisition of skills in subspecialties such as intervention, electrophysiology and echocardiography is arranged informally and locally.

| Full text

March 2005 Br J Cardiol 2005;12:85-9

Living with chest pain

Richard A Best

Abstract

Doctors are encouraged to follow evidence-based
guidelines in the assessment and management of
chest pain. Sometimes following these guidelines
conflicts with clinical experience and even common sense,
as is shown by the contrasting approaches (and outcomes)
to this case .

| Full text

January 2005 Br J Cardiol 2005;12:5-7

Towards sensible eating, how far do we have to go?

Anne Nugent

Abstract

Every day we are bombarded with media headlines and
news stories about obesity, physical inactivity, faddy
diets and ‘miracle’ foods.But how far do we need to go
before we adopt a balanced approach to eating? And what
is our current nutritional status: is it possible to be overweight
yet still have suboptimal nutritional status, particularly with
respect to vitamins and minerals?

| Full text

January 2005 Br J Cardiol 2005;12:9-10

ARBITER-2: judging the next step in lipid management

Anthony S Wierzbicki

Abstract

Statin therapy is established as the basis of lipid-lowering
therapy in all patients with established atherosclerotic
disease.1 However, statin trials show that 50–70% of
cardiovascular events cannot be prevented by statins alone.2,3
This raises the question about the next step that should be
taken to prevent further events in high-risk patients already
on a statin.ITED

| Full text

November 2004 Br J Cardiol 2004;11:449-54

Statin safety in perspective – maximising the risk:benefit

Marc Evans

Abstract

Statins are prescribed worldwide for patients with coronary heart disease (CHD) and also for those at risk of developing atherosclerotic vascular disease. They represent a valuable treatment option for managing lipid levels. However, the well-publicised withdrawal of cerivastatin (Baycol®, Bayer) in 2001 led to concern and much subsequent discussion over the safety of statins. This review looks at the evidence in relation to the benefits and risks of statins and demonstrates that the benefits of statins far outweigh the risks.

| Full text

November 2004 Br J Cardiol 2004;11:425-6

Surgical delusions

David P Taggart, David W Pigott

Abstract

Over the last decade improvements in the anaesthetic,
medical and surgical management of patients
undergoing coronary artery bypass grafting
(CABG), along with refinements in cardiopulmonary bypass,
have resulted in better clinical outcomes.

| Full text

November 2004 Br J Cardiol 2004;11:421-3

Statin prescribing rises and infarct rates plateau. Why the mismatch?

Michael D Feher

Abstract

A recent report in the British Medical Journal has
suggested that the incidence of myocardial infarctions
has only plateaued with the rise in statin prescriptions (BMJ 2004;329:645).
Although this observation does need to be interpreted with caution,
there may be several reasons for this.

| Full text

November 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 77–AIC 79

The potential role for recombinant factor VIIa in cardiac surgery

Paul Diprose, Ravi Gill

Abstract

Recombinant factor VIIa (rFVIIa, Novoseven®, Novo
Nordisk®, Denmark) is established for the management
of bleeding episodes in haemophiliac patients with inhibitors.
Interest has been growing in the use of this drug
for the management of severe intractable bleeding following
major trauma and surgery.

| Full text

September 2004 Br J Cardiol 2004;11:347-9

Fashioning a new approach to heart disease in women

Vahini V Naidoo

Abstract

Implementation of new evidence-based guidelines is one of
the most daunting tasks facing healthcare professionals
today, and in order to meet this challenge we need to be
well informed and to inform our patients.

| Full text

September 2004 Br J Cardiol 2004;11:343-5

Low haemoglobin in patients with chronic heart failure: common but commonly ignored

Paul R Kalra

Abstract

Although studies from two decades ago documented
the association of low haemoglobin with chronic
heart failure (CHF), the potential for an important
pathophysiological link has largely been ignored until recently.
In 2000 Silverberg and colleagues reported on a cohort of
patients (n=142) attending a specialist nephro-cardiology clinic.
1 Anaemia (haemoglobin < 12 g/dL) was present in over half the patients and was associated with symptom severity.

| Full text




Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now